Progressive length-dependent polyneuropathy in xeroderma pigmentosum group A.

Area of Science:

• Neurology
• Genetics
• Dermatology

Background:

• Xeroderma pigmentosum group A (XP-A) is a rare genetic disorder.
• Understanding peripheral nervous system (PNS) involvement in XP-A is crucial for patient management.

Purpose of the Study:

• To investigate the progression of peripheral nervous system involvement in XP-A patients.
• To characterize the electrophysiological and clinical manifestations of XP-A neuropathy.

Main Methods:

• Nerve conduction studies were performed on 17 genetically confirmed XP-A patients.
• Brain MRI was used to analyze gray matter volume (GMV).
• Clinical and skin manifestation severity scores were assessed.

Main Results:

• Significant reductions in motor and sensory nerve action potential amplitudes were observed.
• Mild reductions in nerve conduction velocity were noted, predominantly in sensory nerves and lower limbs.
• Neuropathy showed progressive deterioration with age, evident from early childhood.

Conclusions:

• XP-A patients present with length-dependent axonal polyneuropathy.
• The neuropathy in XP-A progressively worsens from early childhood.
• Electrophysiological findings correlate with clinical observations of PNS involvement.